Literature DB >> 34357406

The prevalence of physical multimorbidity among people with non-affective psychotic disorders 10 years after first diagnosis: a matched retrospective cohort study.

Myanca Rodrigues1, Saverio Stranges1,2,3, Bridget L Ryan1,2, Kelly K Anderson4,5.   

Abstract

AIMS: The higher prevalence of chronic physical health conditions among people with psychotic disorders may result in a reduced life expectancy as compared to the general population. More research is needed on the risk of multiple co-occurring chronic health conditions, known as multimorbidity, for people with psychotic disorders.
METHODS: We conducted a matched retrospective cohort study to quantify the prevalence of multimorbidity and associated factors among people with psychotic disorders over the 10-year period following first diagnosis, relative to those without psychosis. Data from an early psychosis intervention program in London, Canada were linked to population-based health administrative data to identify patients with first-episode psychosis (n = 439), and a comparison group from the general population (n = 1759) matched on age, sex, and postal code. We followed the cohort for 10 years to ascertain the prevalence of multimorbidity. We compared people with and without psychosis using modified Poisson regression models, and explored risk factors for multimorbidity among those with psychotic disorders.
RESULTS: People with psychotic disorders may have a 26% higher prevalence of multimorbidity 10 years following first diagnosis, although our findings include the possibility of a null effect (PR = 1.26, 95% CI 0.96-1.66). People with psychosis living in areas with the highest levels of material deprivation had a threefold higher prevalence of multimorbidity as compared to those in the lowest areas of material deprivation (PR = 3.09, 95% CI 1.21-7.90).
CONCLUSION: Multimorbidity is prevalent among those with psychosis, and assessment for chronic health conditions should be integrated into clinical care for younger populations with psychotic illness.
© 2021. Springer-Verlag GmbH Germany, part of Springer Nature.

Entities:  

Keywords:  Co-occurring chronic conditions; Comorbidity; Multimorbidity; Multiple chronic conditions; Psychotic disorders

Mesh:

Year:  2021        PMID: 34357406     DOI: 10.1007/s00127-021-02157-y

Source DB:  PubMed          Journal:  Soc Psychiatry Psychiatr Epidemiol        ISSN: 0933-7954            Impact factor:   4.328


  24 in total

1.  Multimorbidity and quality of life: Systematic literature review and meta-analysis.

Authors:  Tatjana T Makovski; Susanne Schmitz; Maurice P Zeegers; Saverio Stranges; Marjan van den Akker
Journal:  Ageing Res Rev       Date:  2019-04-30       Impact factor: 10.895

2.  [Problems in the diagnosis of tumors of the pancreas].

Authors:  E M Tareev; O M Vinogradova; A P Solov'e
Journal:  Sov Med       Date:  1985

3.  Gender differences in early onset of chronic physical multimorbidities in schizophrenia spectrum disorder: Do women suffer more?

Authors:  Ivona Šimunović Filipčić; Ena Ivezić; Nenad Jakšić; Nina Mayer; Majda Grah; Martina Rojnić Kuzman; Zarko Bajić; Vesna Svab; Miroslav Herceg; Igor Filipčić
Journal:  Early Interv Psychiatry       Date:  2019-08-14       Impact factor: 2.732

4.  Epidemiology and impact of multimorbidity in primary care: a retrospective cohort study.

Authors:  Chris Salisbury; Leigh Johnson; Sarah Purdy; Jose M Valderas; Alan A Montgomery
Journal:  Br J Gen Pract       Date:  2011-01       Impact factor: 5.386

5.  Psychotic symptoms are associated with physical health problems independently of a mental disorder diagnosis: results from the WHO World Health Survey.

Authors:  Carmen Moreno; Roberto Nuevo; Somnath Chatterji; Emese Verdes; Celso Arango; José Luis Ayuso-Mateos
Journal:  World Psychiatry       Date:  2013-10       Impact factor: 49.548

Review 6.  Is the prevalence of metabolic syndrome and metabolic abnormalities increased in early schizophrenia? A comparative meta-analysis of first episode, untreated and treated patients.

Authors:  Alex J Mitchell; Davy Vancampfort; Amber De Herdt; Weiping Yu; Marc De Hert
Journal:  Schizophr Bull       Date:  2012-08-27       Impact factor: 9.306

7.  Understanding the schizophrenia prodrome.

Authors:  Manju George; Shreemit Maheshwari; Suhas Chandran; J Shivananda Manohar; T S Sathyanarayana Rao
Journal:  Indian J Psychiatry       Date:  2017 Oct-Dec       Impact factor: 1.759

8.  Patterns of symptoms before a diagnosis of first episode psychosis: a latent class analysis of UK primary care electronic health records.

Authors:  Ying Chen; Saeed Farooq; John Edwards; Carolyn A Chew-Graham; David Shiers; Martin Frisher; Richard Hayward; Athula Sumathipala; Kelvin P Jordan
Journal:  BMC Med       Date:  2019-12-04       Impact factor: 8.775

9.  The REporting of studies Conducted using Observational Routinely-collected health Data (RECORD) statement.

Authors:  Eric I Benchimol; Liam Smeeth; Astrid Guttmann; Katie Harron; David Moher; Irene Petersen; Henrik T Sørensen; Erik von Elm; Sinéad M Langan
Journal:  PLoS Med       Date:  2015-10-06       Impact factor: 11.069

10.  Association between Global Assessment of Functioning scores and indicators of functioning, severity, and prognosis in first-time schizophrenia.

Authors:  Ole Köhler; Henriette Thisted Horsdal; Lone Baandrup; Ole Mors; Christiane Gasse
Journal:  Clin Epidemiol       Date:  2016-09-02       Impact factor: 4.790

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.